HB703
(Title) relative to providing notice of the introduction of new high-cost prescription drugs.
BodyDocket Description
H Introduced 01/03/2019 and referred to Commerce and Consumer Affairs HJ 3 P. 27
H Public Hearing: 02/19/2019 02:00 pm LOB 302
H Subcommittee Work Session: 02/21/2019 10:30 am LOB 302
H==RECESSED== Executive Session: 02/21/2019 02:00 pm LOB 302
H Subcommittee Work Session: 03/06/2019 08:30 am LOB 302
H==CONTINUED== Executive Session: 03/08/2019 01:30 pm LOB 302-304
H Subcommittee Work Session: 03/08/2019 09:00 am LOB 302-304
HMajority Committee Report: Ought to Pass with Amendment # 2019-0908h for 03/19/2019 (Vote 13-7; RC) HC 16 P. 22
HMinority Committee Report: Inexpedient to Legislate
HAmendment # 2019-0908h: AA VV 03/19/2019 HJ 10 P. 77
HOught to Pass with Amendment 2019-0908h: MA RC 206-141 03/19/2019 HJ 10 P. 77
S Introduced 03/28/2019 and Referred to Commerce; SJ 12
S Hearing: 05/07/2019, Room 100, SH, 02:15 pm; SC 21
SCommittee Report: Rereferred to Committee, 05/15/2019; Vote 5-0; CC; SC 22
SRereferred to Committee, MA, VV; 05/15/2019; SJ 16
SSen. Sherman Moved to Remove HB 703-FN from the Consent Calendar; 05/15/2019; SJ 16
SCommittee Report: Ought to Pass, 01/08/2020; SC 47
SOught to Pass: MA, VV; OT3rdg; 01/08/2020; SJ 1
SEnrolled (In recess 01/08/2020); SJ 2
HEnrolled 01/09/2020 HJ 2 P. 58
HSigned by Governor Sununu 02/10/2020; Chapter 4; 01/01/2020